TABLE 2.
Continent (no. of countries) | No. of isolatesa
|
No. of isolates with SSCP pattern:b
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|
CIP-S | CIP-R | ICIP-S | ICIP-R1 | ICIP-R2 | ICIP-R3 | IICIP-S | IIICIP-S | IIICIP-R1 | IIICIP-R2 | |
Asia (10) | 7 | 59 | 1 | 3 | 1 | 6 | 54 | 1 | ||
Africa (3) | 4 | 5 | 4 | 5 | ||||||
Central America (1) | 0 | 1 | 1 | |||||||
Europe (9) | 12 | 65 | 6 | 16 | 1 | 2 | 4 | 48 |
CIP-S, ciprofloxacin susceptible (MIC, ≤1 mg/ml); CIP-R, ciprofloxacin-resistant (MIC, ≥4 mg/ml).
SSCP patterns are designated as explained in the text and Table 1.